For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240710:nRSJ7243Va&default-theme=true
RNS Number : 7243V Webis Holdings PLC 10 July 2024
For immediate release
10 July 2024
Webis Holdings plc
("Webis" or the "Group")
Jim Mellon joins the Webis board
Following regulatory approval, the Board of Webis, the global gaming group, is
pleased to announce the appointment of Mr James ("Jim") Mellon as a
Non-Executive Director of the Group. Jim is a well-known entrepreneur,
investor, and author. His interests include biopharma, life sciences,
property, mining, and financial services amongst others. Jim is an honorary
Fellow of Oriel College, Oxford and holds a master's degree in Politics,
Philosophy and Economics from Oxford University. Jim is the beneficial owner
of and Chairman of Burnbrae Group Limited.
Ed Comins, Webis' Managing Director, commented:
"I am delighted to welcome Jim to the Board of Webis. His exceptional
commercial experience will prove invaluable as we continue to implement our
strategy, and we are sure he will make a very positive contribution to the
Board."
James ("Jim") Mellon (age 67)
He has held the following directorships and/or partnerships in the past five
years:
Current Past
Acruity Limited Binary Group Ltd
Agronomics Investment Holdings Limited Binary Investments (Europe) Limited
Agronomics Limited Binary Limited
Albany Management Limited Biogerontology Research Foundation
American Federation of Aging Research Calabrese Holdings Limited
Big Group Limited Extreme Opportunities Limited
Bradda Head International Limited Fast Forward Innovations Limited
Bradda Head Limited Ferrum Limited
Bradda Head Lithium Limited Fixed-Odds Capital (Cook Islands) Ltd
Buck Institute for Research on Aging Global Glory Investment Limited
Burnbrae Germany East GmbH Insilico Medicine Cayman Subco
Burnbrae Germany Limited Insilico Medicine Cayman Topco
Burnbrae Germany Operations GmbH Insilico Medicine Hong Kong Limited
Burnbrae Germany West GmbH Insilico Medicine, Inc.
Burnbrae Group Limited Interman (Hong Kong) Limited
Burnbrae Limited Plethora Solutions Holdings plc
Burnbrae Mitte GmbH Regent Corporate Finance Limited
Burnbrae Sachsen GmbH Regent Fund Management (Asia) Limited
Calabrese Holdings Limited Regent Fund Management Limited
Clean Air Capital Limited Regent Metals Holdings Limited
Clean Food Group Limited Shaanxi Red Dragon Resources Ltd
Compedica Holdings Limited Speymill Deutsche Immobilien plc
Condor Gold Plc Speymill Property Group (UK) Limited
Good Dog Food Limited Wielandstrasse 5 Objekt GmbH
IC Technology (UK) Limited
J2 Music Limited
Juvenescence Limited
LyGenesis, Inc.
Mann Bio Pathfinder Limited
Mann Bioinvest (BVI) Limited
Mann Bioinvest Limited
Manx Financial Group plc
MediqVentures Limited
New Agrarian Company Advisors Limited
New Agrarian Company Limited
Podenco Global Limited
Portage Biotech, Inc
Powered Future Limited
Regent Pacific Group Limited
SABR Holdings Litd
SalvaRx Group Limited
SalvaRx Group PLC
SalvaRx Limited
Shellbay Investments Limited
Sleepwell Hotels (UK) Limited
Sleepwell Hotels Limited
The Longevity Forum Limited
Titec (BVI) Limited
Winter Limited
Wolseley Managers Limited
Jim Mellon holds 248,204,442 shares in the Group in the name of Burnbrae
Limited, representing 63.1% of the issued capital.
Further information on Mr Mellon which required to be disclosed under Schedule
Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies is set out in the
Appendix.
The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 ("MAR").
For further information:
Webis Holdings plc Tel: 01624 639396
Denham Eke
Beaumont Cornish Limited Tel: 020 7628 3396
Roland Cornish/James Biddle
Appendix: Further disclosure under Schedule Two, paragraph (g) (i)-(viii) of
the AIM Rules for Companies
Jim Mellon was a director of Regent Global Fund and Undervalued Assets Greater
China Fund Series III, both of which went into voluntary liquidation. These
two funds were liquidated with the consent of shareholders as the directors
recommended that, due to a decline in the size of the funds, they were
uneconomic. There were no unsatisfied creditors.
Bigsave Holdings plc, a company of which Jim Mellon was a director, entered
into a voluntary liquidation. There were no unsatisfied creditors.
On 8 April 2003, Regent Pacific Fund, a company of which Jim Mellon was a
director, entered into a voluntary liquidation. There were no unsatisfied
creditors.
On 9 December 2005, Undervalued Assets Fund - Series One, a company of which
Jim Mellon was a director, entered into a voluntary liquidation. There were no
unsatisfied creditors.
On 5 February 2008, Asian Opportunity Fund 1998 - Series I, commenced
voluntary liquidation pursuant to its Articles and Association. Jim Mellon was
a director within the 12 month periods preceding such date. There were no
unsatisfied creditors.
On 29 January 2014, Rivington Street Holdings plc, a company of which Jim
Mellon was a director, entered into a voluntary liquidation. The creditors
were owed approximately £4 million, of which Jim Mellon and his interests
were owed £3.8 million.
On 3 September 2015, Speymill plc, a company of which Jim Mellon was a
director, entered into a voluntary liquidation and was subsequently dissolved
on 6 July 2017. The combined creditors of the Speymill Group were
approximately £4.3 million, of which Jim Mellon and his interests were owed
£3.9 million.
There was an historic arrest warrant for Jim Mellon, issued by the Seoul South
Korea prosecutor's office on 19 December 2000 and subsequently reissued on 14
January 2004. The warrant was due to remain valid and effective until 12 March
2010. The arrest warrant pertains to an alleged involvement in a conspiracy to
manipulate the share price of Regent Securities Co., Ltd. Mr Mellon has
informed the Company that he absolutely and categorically denies that this
allegation has any substance. No evidence was produced against him and no
further proceedings have taken place with no further developments in this
matter since 2010.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAUKUURSVUBRAR